Glaukos (GKOS) Revenue Growth (3y) (2017 - 2026)
Glaukos (GKOS) Revenue Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 8.07% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 9.66% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 14.78% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 10.83% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 14.51% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 3.20% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 25.44% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 8.05% |
| 10 | Glaukos | 10.92 Bn | 10.80 Bn | 151.59 Mn | 32.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.17% |
| Mar 31, 2026 | 26.78% |
| Dec 31, 2025 | 26.19% |
| Sep 30, 2025 | 23.28% |
| Jun 30, 2025 | 19.53% |
| Mar 31, 2025 | 16.37% |
| Dec 31, 2024 | 12.94% |
| Sep 30, 2024 | 8.97% |
| Jun 30, 2024 | 7.01% |
| Mar 31, 2024 | 8.00% |
| Dec 31, 2023 | 3.99% |
| Sep 30, 2023 | 6.38% |
| Jun 30, 2023 | 36.58% |
| Mar 31, 2023 | 10.12% |
| Dec 31, 2022 | 2.65% |
| Sep 30, 2022 | 6.80% |
| Jun 30, 2022 | 7.44% |
| Mar 31, 2022 | 7.80% |
| Dec 31, 2021 | 10.64% |
| Sep 30, 2021 | 19.38% |